Improving glucose management:: Ten steps to get more patients with type 2 diabetes to glycaemic goal -: Recommendations from the Global Partnership for Effective Diabetes Management

被引:111
作者
Del Prato, S
Felton, AM
Munro, N
Nesto, R
Zimmet, P
Zinman, B
机构
[1] Univ Pisa, Dept Endocrinol & Metab, Sect Diabet, Osped Cisanello, I-56124 Pisa, Italy
[2] Federat European Nurses Diabet, London, England
[3] Primary Care Diabet Europe, Surrey, England
[4] Lahey Clin Fdn, Burlington, MA USA
[5] Int Diabet Inst, Caulfield, Australia
[6] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
关键词
glycaemic control; glycaemic targets; patient management; type; 2; diabetes;
D O I
10.1111/j.1742-1241.2005.00674.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite increasingly stringent clinical practice guidelines for glycaemic control, the implementation of recommendations has been disappointing, with over 60% of patients not reaching recommended glycaemic goals. As a result, current management of glycaemia falls significantly short of accepted treatment goals. The Global Partnership for Effective Diabetes Management has identified a number of major barriers that can prevent individuals from achieving their glycaemic targets. This article proposes 10 key practical recommendations to aid healthcare providers in overcoming these barriers and to enable a greater proportion of patients to achieve glycaemic goals. These include advice on targeting the underlying pathophysiology of type 2 diabetes, treating early and effectively with combination therapies, adopting a holistic, multidisciplinary approach and improving patient understanding of type 2 diabetes. Implementation of these recommendations should reduce the risk of diabetes-related complications, improve patient quality of life and impact more effectively on the increasing healthcare cost related to diabetes.
引用
收藏
页码:1345 / 1355
页数:11
相关论文
共 95 条
[91]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853
[92]   Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000 [J].
Unal, B ;
Critchley, JA ;
Capewell, S .
CIRCULATION, 2004, 109 (09) :1101-1107
[93]   Gut peptides in the treatment of diabetes mellitus [J].
Vahl, TP ;
D'Alessio, DA .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (03) :177-188
[94]   Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients - The Verona Diabetes Study [J].
Verlato, G ;
Muggeo, M ;
Bonora, E ;
Corbellini, M ;
Bressan, F ;
deMarco, R .
DIABETES CARE, 1996, 19 (03) :211-213
[95]   The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus [J].
Weyer, C ;
Bogardus, C ;
Mott, DM ;
Pratley, RE .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :787-794